Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 1.39% is 694% above its 5-year average of -0.23%, around the middle of its 5-year range (-7.01%–9.25%).
42.25% below its 12-month average of 2.41%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 3.46%.
NET PROFIT MARGIN
1.39%
NET PROFIT MARGIN AVG TTM
2.41%
NET PROFIT MARGIN AVG 3Y
-1.07%
NET PROFIT MARGIN AVG 5Y
-0.23%
NET PROFIT MARGIN AVG 10Y
3.44%
NET PROFIT MARGIN AVG 15Y
6.54%
NET PROFIT MARGIN AVG 20Y
8.05%
CURRENT VS TTM AVG
-42.25%
CURRENT VS 3Y AVG
+230.21%
CURRENT VS 5Y AVG
+694.03%
CURRENT VS 10Y AVG
-59.56%
CURRENT VS 15Y AVG
-78.76%
CURRENT VS 20Y AVG
-82.72%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+634.62%
vs the sector median at left
ICU Medical, Inc.
Market Cap
$3.97B
Net Profit Margin
1.39%
TTM Avg
2.41%
3Y Avg
-1.07%
5Y Avg
-0.23%
Market Cap
$4.02B
Net Profit Margin
-2763.64%
TTM Avg
-2587.65%
3Y Avg
-6887.52%
5Y Avg
-6604.41%
Market Cap
$4.05B
Net Profit Margin
-248.83%
TTM Avg
-379.86%
3Y Avg
-278.01%
5Y Avg
-170.03%
Market Cap
$3.82B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.14B
Net Profit Margin
12.82%
TTM Avg
-6.21%
3Y Avg
-4.84%
5Y Avg
-11.63%
Market Cap
$4.29B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.58B
Net Profit Margin
20.37%
TTM Avg
9.12%
3Y Avg
-3.67%
5Y Avg
-13.14%
Market Cap
$3.56B
Net Profit Margin
-1.69%
TTM Avg
-12.55%
3Y Avg
-19.61%
5Y Avg
-21.06%
Market Cap
$4.40B
Net Profit Margin
-20.73%
TTM Avg
-55.30%
3Y Avg
-87.73%
5Y Avg
-105.64%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ICU Medical, Inc. (ICUI) | $3.97B | 1.39% | 2.41% | -1.07% | -0.23% |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.02B | -2763.64% | -2587.65% | -6887.52% | -6604.41% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.05B | -248.83% | -379.86% | -278.01% | -170.03% |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.82B | 0.00% | 0.00% | 0.00% | 0.00% |
| LivaNova PLC (LIVN)vs › | $4.14B | 12.82% | -6.21% | -4.84% | -11.63% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.29B | 0.00% | 0.00% | 0.00% | 0.00% |
| Veracyte, Inc. (VCYT)vs › | $3.58B | 20.37% | 9.12% | -3.67% | -13.14% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.56B | -1.69% | -12.55% | -19.61% | -21.06% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.40B | -20.73% | -55.30% | -87.73% | -105.64% |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.51B | -229.92% | -236.29% | -296.56% | -337.05% |
Operating Margin
5.0%
Net Profit Margin
1.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 3.46% |
| 2026-03-31 | 5.68% |
| 2025-12-31 | -2.91% |
| 2025-09-30 | -0.63% |
| 2025-06-30 | 6.44% |
| 2025-03-31 | -2.56% |
| 2024-12-31 | -3.78% |
| 2024-09-30 | -5.60% |
| 2024-06-30 | -3.59% |
| 2024-03-31 | -6.97% |
| 2023-12-31 | -2.92% |
| 2023-09-30 | 1.31% |
| 2023-06-30 | -1.81% |
| 2023-03-31 | -1.73% |
| 2022-12-31 | -2.69% |
| 2022-09-30 | -2.21% |
| 2022-06-30 | -1.33% |
| 2022-03-31 | -7.01% |
| 2021-12-31 | 5.85% |
| 2021-09-30 | 9.25% |
| 2021-06-30 | 8.83% |
| 2021-03-31 | 7.46% |
| 2020-12-31 | 8.16% |
| 2020-09-30 | 7.84% |
| 2020-06-30 | 6.23% |
| 2020-03-31 | 5.12% |
| 2019-12-31 | 6.54% |
| 2019-09-30 | 8.64% |
| 2019-06-30 | 7.31% |
| 2019-03-31 | 9.37% |
| 2018-12-31 | -2.16% |
| 2018-09-30 | 0.07% |
| 2018-06-30 | 8.62% |
| 2018-03-31 | 1.31% |
| 2017-12-31 | 13.43% |
| 2017-09-30 | 0.04% |
| 2017-06-30 | -11.18% |
| 2017-03-31 | 22.55% |
| 2016-12-31 | 9.94% |
| 2016-09-30 | 19.37% |
| 2016-06-30 | 17.17% |
| 2016-03-31 | 20.21% |
| 2015-12-31 | 6.04% |
| 2015-09-30 | 18.91% |
| 2015-06-30 | 16.20% |
| 2015-03-31 | 11.89% |
| 2014-12-31 | 9.23% |
| 2014-09-30 | 8.30% |
| 2014-06-30 | 7.47% |
| 2014-03-31 | 9.09% |
| 2013-12-31 | 17.11% |
| 2013-09-30 | 13.32% |
| 2013-06-30 | 9.37% |
| 2013-03-31 | 11.69% |
| 2012-12-31 | 14.93% |
| 2012-09-30 | 14.97% |
| 2012-06-30 | 11.84% |
| 2012-03-31 | 10.07% |
| 2011-12-31 | 23.33% |
| 2011-09-30 | 12.11% |
| 2011-06-30 | 12.20% |
| 2011-03-31 | 11.30% |
| 2010-12-31 | 13.21% |
| 2010-09-30 | 11.85% |
| 2010-06-30 | 11.20% |
| 2010-03-31 | 6.61% |
| 2009-12-31 | 10.64% |
| 2009-09-30 | 11.72% |
| 2009-06-30 | 10.75% |
| 2009-03-31 | 13.00% |
| 2008-12-31 | 15.83% |
| 2008-09-30 | 13.97% |
| 2008-06-30 | 9.82% |
| 2008-03-31 | 6.49% |
| 2007-12-31 | 13.20% |
| 2007-09-30 | 10.49% |
| 2007-06-30 | 5.20% |
| 2007-03-31 | 20.10% |
| 2006-12-31 | 12.99% |
| 2006-09-30 | 12.64% |
| 2006-06-30 | 12.24% |
| 2006-03-31 | 13.05% |
| 2005-12-31 | 12.29% |
| 2005-09-30 | 12.48% |
| 2005-06-30 | 11.65% |
| 2005-03-31 | 16.31% |
| 2004-12-31 | -9.97% |
| 2004-09-30 | -6.29% |
| 2004-06-30 | 15.74% |
| 2004-03-31 | 18.62% |
| 2003-12-31 | 24.03% |
| 2003-09-30 | 16.36% |
| 2003-06-30 | 18.32% |
| 2003-03-31 | 22.97% |
| 2002-12-31 | 24.39% |
| 2002-09-30 | 21.27% |
